Voya Financial Advisors, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Voya Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $152,933 - $214,998	-1,270 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $161,518 - $220,865	1,270 New	1,270 $210,000
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $534,714 - $735,331	-4,157 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $527,232 - $730,343	4,157 New	4,157 $562,000

638

108M

2.33M

2.15M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.